AC
DALS

Aristeia Capital’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Aristeia Capital’s Portfolio DALS Stock Details DALS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-305,800
Closed -$3.14M – 297
2023
Q2 		$3.14M Buy
305,800
+800
+0.3% +$8.16K 0.07% 92
2023
Q1 		$3.09M Buy
+305,000
New +$3.07M 0.07% 180

Aristeia Capital's DALS Position: Q3 2023 in Review

Aristeia Capital sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 305,800 shares — an estimated $3.14M sold.

Aristeia Capital first reported a position in DALS in Q1 2023 and held it in 2 quarters. The position peaked at $3.14M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Aristeia Capital reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Aristeia Capital sold 305,800 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $3.14M.
  • Aristeia Capital first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q1 2023 and held it in 2 quarters.
  • Aristeia Capital's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $3.14M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Aristeia Capital's 13F filing for Q3 2023, filed 14 Nov 2023.